Colistimethatnatrium Xellia

Colistimethate Sodium by Xellia Pharmaceuticals Aps is an antibiotic used for severe infections. Learn about its intravenous and intrathecal applications and safety precautions.

Colistimethate Sodium is primarily used to treat serious bacterial infections, including those resistant to other antibiotics. It is administered intravenously or intrathecally, depending on the infection's location and severity. This medication is often considered for infections caused by multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa. Healthcare providers may prescribe Colistimethate Sodium when other treatment options are ineffective or unsuitable.

Common effects of Colistimethate Sodium may include nephrotoxicity and neurotoxicity, particularly with higher doses or prolonged use. Patients might experience symptoms such as dizziness, confusion, or kidney dysfunction. Monitoring for these effects is essential during treatment to ensure patient safety and adjust dosages as needed.

Colistimethate Sodium should be used with caution in patients with pre-existing kidney or neurological conditions. Regular monitoring of kidney function and neurological status is recommended. It is crucial to follow healthcare provider instructions regarding dosage and administration to minimize the risk of adverse effects. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Colistimethate Sodium may interact with other nephrotoxic or neurotoxic medications, increasing the risk of adverse effects. It is important to avoid concurrent use with drugs that can damage the kidneys or nervous system. Patients should also be cautious when consuming alcohol, as it may exacerbate the medication's side effects. Always consult a healthcare provider before starting or stopping any medication while using Colistimethate Sodium.